Dopamine constricts porcine pial veins

European Journal of Pharmacology

Volumn 334, Issue 2-3, 1997, Pages 165-171

  Sun, Man Hua ^a   Ishine, Takaaki ^a   Lee, Tony Jer Fu ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 adrenoceptors; Constriction; Dopamine D1 receptor; Dopamine D2 receptor; Pial vein; Porcine

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; BUTACLAMOL; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GUANETHIDINE; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; QUINPIROLE; SULPIRIDE; TRIETHYLPHOSPHINE GOLD; YOHIMBINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SWINE; VEIN; VENOCONSTRICTION;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CEREBRAL VEINS; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FEMALE; MALE; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SWINE; VASOCONSTRICTION;

EID: 0030882454     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01166-7     Document Type: Article

References (35)

1. 2-adrenoceptors mediate norepinephrine constriction of porcine pial veins. Am. J. Physiol. 263, H1907.
2. Brodde, O.-E., 1982. Vascular dopamine receptors: demonstration and characterization by in vitro studies. Life Sci. 31, 289.
3. 2 receptors. Behavioral and Neural Biol. 56, 283.
4. Civelli, O., Bunzow, J.R., Grandy, D.K., 1993. Molecular diversity of the dopamine receptors. Ann. Rev. Pharmacol. Toxicol. 32, 281.
5. 1 dopamine receptor binding in a rat model of focal cerebral ischemia. Brain Res. 577, 210.
6. De Keyser, J., Ebinger, G., Backer, J.-P.D., Covents, A., Vanderhey, P., Vanquelin, G., 1988. Subtypes of adrenergic and dopaminergic receptors in bovine cerebral blood vessels. Neurosci. Lett. 85, 272.
7. Edvinsson, L., MacKenzie, E.T., 1977. Amine mechanisms in the cerebral circulation. Pharmacol. Rev. 28, 275.
8. Fleming, W.W., Westfall, D.P., De La Lande, I.S., Jellett, L.B., 1972. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 181, 339.
9. Forster, C., Drew, G.M., Hilditch, A., Whalley, E.T., 1983. Dopamine receptors in human basilar arteries. Eur. J. Pharmacol. 87, 227.
10. 2 agonist, N-0437, on vascular adrenergic responses. J. Pharmacol. Exp. Ther. 250, 853.
11. Goldberg, L.I., Volkman, P.H., Kohli, J.D., 1978. A comparison of the vascular dopamine receptor with other dopamine receptors. Ann. Rev. Pharmacol. Toxicol. 18, 57.
12. Goldberg, L.I., 1984. Dopamine receptors and hypertension. Physiologic and pharamcologic implication, Am. J. Med. 77, 37.
13. Hughes, A., Inkpen, P., Sever, P., 1988. Action of dopamine on isolated human saphenous veins. J. Cardiovasc. Pharmacol. 11, 373.
14. Kao, T.Y., Chio, C.C., Lin, M.T., 1994. Hypothalamic dopamine release and local cerebral blood flow during onset of heat stroke in rats. Stroke 25, 2483.
15. Kebabian, J.W., Calne, D.B., 1979. Multiple receptors for copamine. Nature 277, 93.
16. Kelley, M.J., 1982. Evidence for the presence of vascular dopamine receptors in the rabbit. Meth. Find. Exp. Clin. Pharmacol. 4, 365.
17. Kohli, J.D., Goldberg, L.I., 1987. A classification based on physiological studies. In: Greese, I., Fraser, C.M. (Eds.), Dopamine receptors, Alan R. Liss, Inc., p. 97.
18. Lee, T.J.-F., Ueno, M., Sunagane, N., Sun, M.H., 1994. Serotonin relaxes porcine pial veins. Am. J. Physiol 266, H1000.
19. Lokhandwala, M.F., Hedge, S.S., 1990. Cardiovascular dopamine receptor agonist, in: F. Amenta (Ed.), Peripheral Dopamine Pathophysiology, CRC Press, Boca Raton, p. 63.
20. Marin, J., Rivilla, F., 1982. Nerve endings and pharmacological receptors in cerebral vessels. Gen. Pharmacol. 13, 361.
21. 2 receptor agonist, in the conscious rat. J. Pharmacol. Exp. Ther. 236, 755.
22. Nau, R., Sander, D., Kleingelhoben, J., 1992. Relationships between dopamine infusions and intracranial hemodynamics in patients with raised intracranial pressure. Clinical Neurol. Neurosurg. 94, 143.
23. 1 dopamine receptor: Synthesis and characterization of R(+) and 5(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue. J. Med. Chem. 35, 1466.
24. O'Dowd, B.F., 1993. Structures of dopamine receptors. J. Neurochem. 60, 804.
25. Okamura, T., Yamazaki, M., Toda, N., 1991. Responses to dopamine of isolated human and monkey veins compared with those of the arteries. J. Pharamcol. Exp. Ther. 258, 275.
26. Oudart, N., Sercombe, R., Aubineau, P., Boulu, R.G., Seylaz, J., 1981. Relaxation by dopaminergic agonists in cerebral and peripheral arteries. Arch In. Pharmacodynamine 252, 196.
27. Ricci, A., Collier, W.L., Amenta, F., 1994. Pharmacological characteristic and autoradiographic localization of dopamine receptors in the portal vein. J. Autonomic Pharmacol. 14, 61.
28. Sharkey, J., McCulloch, J., 1986. Dopaminergic mechanisms in the regulation of cerebral blood flow and metabolism: role of different receptor subtypes. In: Owman, C., Hardebo, J.E. (Eds.), Neural regulation of brain circulation, Elsevier Science, Amsterdam, p. 111.
29. Sibley, D.R., Monsma, F.J. Jr., 1992. Molecular biology of dopamine receptor. TIPS 13, 61.
30. Toda, N., 1976. Influence of dopamine and noradrenaline on isolated cerebral arteries of the dog. British J. Pharmacol. 48, 121.
31. Toda, N., 1983a. Heterogeneity in the response to dopamine of monkey cerebral and peripheral arteries. Am. J. Physiol. 245, H930.
32. Toda, N., 1983b. Dopamine vasodilates human cerebral artery. Experientia (Basel) 607, 270.
33. 1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation. Brain Res. 607, 270.
34. 1-like receptor subtype mediates cAMP synthesis in porcine pial vein. Am. J. Physiol. 268, H1383.
35. 2 receptor. TIPS 10, 74.